About this trial
This study aims to determine if oral dexamethasone provides clinically significant improvement in postoperative outcomes, specifically nausea and pain scores.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult patients age 18 and older who will be undergoing joint replacement
Disqualifiers
Patients with uncontrolled diabetes ( HbA1C, >7.5%), impaired hepatic function (Child class, >B), impaired renal failure (Glomerular filtration rate <60 mL/min/1.73 m2), chronic narcotic use, alcohol and/or opioid dependence, patients with a known adverse reaction to corticosteroids, and patients unable to give informed consent.
Trial design
Parallel
Treatments tested in this trial
Dexamethasone
Drug4 mg bid for 4 days
Placebo
Drugoral placebo
Treatment groups
Trial outcomes
Primary outcomes
Postoperative Pain
Postoperative pain will be collected via visual analog scores
Postoperative Nausea
Postoperative Nausea will be collected via visual analog scores
Opioid Consumption
Opioid consumption will be recorded by participant in assigned journal, morphine equivalence will be recorded
Antiemetic Consumption
Secondary outcomes
Postoperative complications
Incidence of surgical site infection, acute prosthetic joint infection
Patient-reported outcome scores (PROMS)
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: